PledPharma strengthens the management team with a Vice

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
124
PledPharma strengthens the management team with a Vice President Product Strategy and Development

Stockholm, 2017-06-29 08:00 CEST (GLOBE NEWSWIRE) -- PledPharma announces today that Christian Sonesson has been appointed to the newly created position as Vice President Product Strategy and Development. He will lead the continued development program of the company's drug candidate PledOx ® , as well as being responsible for the design of pricing strategies, initial market positioning and expansion of potential indications.

"We are pleased to welcome Christian Sonesson to PledPharma. The appointment is an important part of the work to further strengthen the organization prior to the completion of the remaining clinical studies and the parallel preparations for a successful commercialization of the company's most advanced project, PledOx ® , a potentially new drug for preventing nerve damage caused by chemotherapy treatment", said PledPharmas CEO, Nicklas Westerholm.

Christian Sonesson holds an Executive MBA from the Stockholm School of Economics and a PhD in Biostatistics from the University of Gothenburg. He has been 13 years at AstraZeneca and most recently as Director Global Products, where he was responsible for overall project strategies and the delivery of comprehensive Phase III clinical trials. Christian also has extensive experience of interactions with regulatory authorities and from successful registrations of new drug candidates in different regions.

Christian is joining PledPharma on August 15, 2017.

For more information, please contact :

Nicklas Westerholm, CEO, phone: +46 73 354 20 62

Nicklas.westerholm@pledpharma.se

Michaela Gertz, CFO, phone: +46 709 26 17 75

Michaela.gertz@pledpharma.se

About PledPharma

PledPharma develops new drugs that protect the body against oxidative stress – a potentially debilitating and sometimes life-threatening condition that can be caused by chemotherapy treatment and following acetaminophen (paracetamol) overdose. The company's most advanced project PledOx ® is being developed to reduce nerve damage associated with chemotherapy. A phase IIb study has been conducted and will serve as the basis for the continued development. The drug candidate Aladote ® is being developed to reduce the risk of acute liver failure associated with acetaminophen poisoning. PledPharma (STO: PLED) is listed on Nasdaq First North. Erik Penser Bank is the company’s Certified Adviser ( tel +46 8 463 80 00) . For more information, see www.pledpharma.se

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Navigating Simultaneous Home Buy and Sell Strategies

Updated Category News Views 53

Juggling Two Housing Transactions You ever tried juggling chainsaws? That's what buying and selling your home at the same time can feel like. Selling First: Playing It Safe Some folks swear by selling their current home first, and there's good reason. It locks in your financial windfall, giving you a clear picture of your down payment and affordability. No more guessing...

Continue Reading
Villas of Distinction Shines: Bags 11th Gold Travvy

Updated Category News Views 82

Claiming Top Spot Repeatedly Another year, another accolade—Villas of Distinction has clutched its 11th Gold Travvy Award for "Best Villa Rental Company – Overall." This accolade ain't no small potatoes, as it's a testament to the company's unwavering excellence recognized by travel advisors worldwide. These folks, who have their fingers on the pulse of the industry,...

Continue Reading
Stellus Capital Delivers Solid Q3 Amid Turbulent Times

Updated Category News Views 49

Unpacking Stellus Capital's Latest Quarter Boy, Stellus Capital sure knows how to keep us on our toes. In a landscape where many are still reeling from the latest market tremors, they post some solid Q3 numbers for September 30, 2026. Not without its hiccups, but hey, who isn’t stumbling a bit right now? Financial Snapshot: Stability Amidst Uncertainty Stellus reported...

Continue Reading
GCC's Path to 10 Gbps: U6GHz Revolution Unfolds

Updated Category News Views 61

On the Journey to 10 Giga: The U6GHz Leap You know, sometimes the telco world kicks up a fuss about speed, and this time, it’s the upper 6 GHz (or U6GHz) band that’s got everyone abuzz. At the Telecom Review Leaders' Summit in Dubai, industry bigwigs gathered to discuss how this spectrum could catapult the GCC into the 10 Gbps connectivity stratosphere. Fancy-talk...

Continue Reading
Cohen & Steers Sees Steady Rise in October AUM

Updated Category News Views 49

Market Pushes Cohen & Steers Forward It's been a wild ride for financial managers lately, and Cohen & Steers, Inc. (NYSE: CNS) isn't exempt from the rollercoaster. As of October 31, 2026, they've reported assets under management (AUM) climbing to $99.6 billion—thanks to a hefty market appreciation of $4 billion. Not too shabby when you're dealing with the...

Continue Reading
Texas Author's Memoir Journeys Through Trauma and Growth

Updated Category News Views 101

Finding Clarity Amid Chaos When life throws the unexpected, some folks crumble, but others, like Joyce L. Skala, sift through the rubble for clarity. Her debut memoir, "There's No Such Thing as Bad," weaves through personal chaos—embracing trauma and loss like a late-night poker game where the house always wins. Born from the charred memories of her family's home...

Continue Reading
Ionis Faces Legal Scrutiny Amid Slashed Sales Forecast

Updated Category News Views 57

Ionis Pharmaceuticals Takes a Hit: What's Happening? November 9, 2026, wasn't just another dreary market day—especially if you've got a stake in Ionis Pharmaceuticals. Today, they whittled down their full-year sales forecast for TRYNGOLZA from a cozy $100 million to $110 million range to a startling $50 million. NASDAQ: IONS shares naturally took a nosedive, and as...

Continue Reading
TCL Tablets Arrive on BestBuy.com: What It Means

Updated Category News Views 86

Go Big or Go Home: TCL's Bold Move TCL just dropped a little bombshell that's gonna ripple through the electronics retail market—its tablets and smartphones are now bright and shiny on BestBuy.com. It's like standing at the craps table and before you know it, the stakes have just doubled. Why? Best Buy ain't some hole-in-the-wall spot. It's the premium electronics...

Continue Reading
Quantinuum & RIKEN Propel Japan's Quantum Leap Forward

Updated Category News Views 56

Quantum Computing: Japan's Bold New Frontier Quantum computing's buzz is getting louder, and the big players like Quantinuum and RIKEN ain't sitting on their hands. They've rolled up their sleeves to ramp up Japan's quantum-AI supercomputing game with the recent beef-up of Quantinuum's Reimei to its H2 system, putting Japan at the cutting edge of hybrid computing. The...

Continue Reading
Routeware's AI Tech Transforming Waste Management

Updated Category News Views 177

Transforming Waste Management through AI The waste and recycling game just got a facelift with Routeware's latest AI-powered tools. Right out of Austin, Texas, they're throwing down with Routeware Pulse, a fresh AI data and analytics platform that promises to revolutionize how operators handle their reporting and decision-making. It’s no fluff—they’re talking...

Continue Reading

Top 5 Most Recently Viewed Articles

Technogym Launches Revolutionary RUN X World Treadmill Championship

Updated Category News Views 295

Introducing RUN X: A New Era in Treadmill Championships Welcome to the inaugural indoor virtual running competition designed to unite both professional athletes and fitness enthusiasts in gyms worldwide. Technogym, recognized as a leader in wellness and athletic training, is partnering with World Athletics to unveil RUN X, the first World Treadmill Championship. This...

Continue Reading
Record-breaking Fundraising by Fred’s Team for Cancer Research

Updated Category News Views 320

Fred’s Team Achieves Remarkable Fundraising Milestone In an inspiring display of community strength, Fred’s Team has set a new fundraising record, raising an impressive $8,529,723 for cancer research. This amount was collected through the dedicated efforts of runners and supporters, all channeling their passion for running into a greater cause – combating cancer....

Continue Reading
Is MicroStrategy the Smartest Bitcoin Investment Today?

Updated Category News Views 62

Understanding MicroStrategy's Distinct Investment Strategy MicroStrategy (NASDAQ: MSTR) has emerged as a preferred option for numerous investors looking to gain exposure to Bitcoin (BTC). Over the past three years, the performance comparison between MicroStrategy and Bitcoin reveals a striking difference: MicroStrategy has delivered returns of approximately 177% compared...

Continue Reading
TOMI Environmental Solutions Set for Investor Conference Insight

Updated Category News Views 163

TOMI Environmental Solutions to Engage Investors at Upcoming Conference TOMI Environmental Solutions, Inc. (NASDAQ: TOMZ), a leading figure in the field of disinfection and decontamination, is gearing up to participate in an influential investor conference taking place virtually this December. This event will be a great opportunity for the company to showcase its...

Continue Reading
Chartise Clark Joins Stanton Chase as Nonprofit Leader

Updated Category News Views 256

Chartise Clark Joins Stanton Chase as Managing Director Appointment aligns with growth in leadership needs for nonprofits Stanton Chase, a leading executive search firm, is excited to announce that Chartise Clark has been appointed as the Managing Director of its Social Impact, Government, and Education practice. In her new role, Clark will focus on enhancing Stanton...

Continue Reading